Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jokke Wynants"'
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1140-1145 (2024)
Introduction: Treatment with topotecan is standard-of-care therapy for relapsed small-cell lung cancer (SCLC). Both oral and intravenous administrations of topotecan have been extensively researched and are found to be equally effective with less adv
Externí odkaz:
https://doaj.org/article/4c23d0a866b149489e2227808b19f841
Autor:
Aaron Caeyman, Olivia Vandekerckhove, Karin Pat, Jokke Wynants, Karolien Weytjens, Isabelle De Wergifosse, Kristof Cuppens
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1095-1099 (2023)
In this report, we present a patient with metastatic non-small cell lung cancer who developed Sjögren’s syndrome secondary to immune checkpoint inhibition. This patient had a typical clinical presentation as well as biochemical signature, developi
Externí odkaz:
https://doaj.org/article/d9dc62c6c5e140ce9d3ec56fe72f26b0
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 2, Pp 625-630 (2019)
Epidermal growth factor receptor (EGFR)-targeted therapy has become standard of care in advanced stages EGFR-mutant non-small cell lung cancer. Acquired resistance to first-line EGFR-tyrosine kinase inhibitor (TKI) and subsequent disease progression
Externí odkaz:
https://doaj.org/article/feeb2b8f58d74f489cca4e3570319897
Autor:
Jan Verwerft, Lucie Soens, Jokke Wynants, Marc Meysman, Siddharth Jogani, Danielle Plein, Sarah Stroobants, Lieven Herbots, Frederik H Verbrugge
Publikováno v:
European Heart Journal. 44:1544-1556
Background and aims Heart failure with preserved ejection fraction (HFpEF) is a syndrome with a heterogeneous presentation. This study provides an in-;depth description of haemodynamic and metabolic alterations revealed by systematic assessment throu
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 12, Iss 2, Pp 625-630 (2019)
Case Reports in Oncology, Vol 12, Iss 2, Pp 625-630 (2019)
Epidermal growth factor receptor (EGFR)-targeted therapy has become standard of care in advanced stages EGFR-mutant non-small cell lung cancer. Acquired resistance to first-line EGFR-tyrosine kinase inhibitor (TKI) and subsequent disease progression
Autor:
Claus Vogelmeier, Rob Janssen, Christel Haenebalcke, Marko Topalovic, Nilakash Das, Emiel F.M. Wouters, Huib A. M. Kerstjens, Pierre-Régis Burgel, Christophe Pison, Renaud Louis, Marc Schlesser, Piet Vercauter, Giuseppe Liistro, Eric Derom, Wim Janssens, Vincent Ninane, Jokke Wynants, Marc Daenen
Publikováno v:
Clinical Problems.
Introduction: The use of pulmonary function tests (PFT) is built on an expert opinion. PFT interpretation relies on the recognition of patterns but scarcely leads to a specific respiratory disease diagnosis. We aimed to explore the accuracy and inter
Autor:
Richard K. Albert, Mark S. Allen, Charles W. Atwood, Marie Christine Aubry, Alan F. Barker, Peter J. Barnes, Thomas Benfield, Surinder S. Birring, Chris T. Bolliger, Lukas Brander, Roy G. Brower, Jeremy Brown, Todd M. Bull, Philippe Camus, Christopher Carlsten, Stephen D. Cassivi, Moira Chan-Yeung, Jessica Y. Chia, Chung-Wai Chow, Thomas V. Colby, Christopher D. Coldren, Jean-François Cordier, Ulrich Costabel, Vincent Cottin, Gerard J. Criner, Bruce H. Culver, Charles L. Daley, Helen E. Davies, Marc Decramer, Claude Deschamps, Andreas H. Diacon, Christophe Dooms, Ryan H. Dougherty, Neil J. Douglas, Gregory P. Downey, Scott E. Evans, Timothy W. Evans, Jean-William Fitting, Rodney J. Folz, Edward R. Garrity, Brian K. Gehlbach, Mark W. Geraci, Rik Gosselink, E. Brigitte Gottschall, Michael P. Gruber, J.C. Grutters, Jesse B. Hall, David M. Hansell, Inderjit K. Hansra, Felix J.F. Herth, Nicholas S. Hill, Stella E. Hines, Richard Hubbard, Gérard J. Huchon, Leonard D. Hudson, John R. Hurst, Michael C. Iannuzzi, James R. Jett, Joel D. Kaufman, Victor Kim, Coenraad F.N. Koegelenberg, John W. Kreit, Michael J. Krowka, Daniel Langer, Stephen E. Lapinsky, Stephen C. Lazarus, Y.C. Gary Lee, Sylvie Leroy, Marc C.I. Lipman, William MacNee, Jean-Luc Malo, Ryan M. McGhan, Sarah McKinley, David E. Midthun, Robert F. Miller, Theo J. Moraes, Jeffrey L. Myers, Margaret J. Neff, Lee S. Newman, Eric J. Olson, Simon P.G. Padley, Martyn R. Partridge, Ian D. Pavord, Joanna C. Porter, Antoine Rabbat, Felix Ratjen, Anna K. Reed, Melissa L. Rosado-de-Christenson, Cecile S. Rose, Charis Roussos, Luis G. Ruiz, Jay H. Ryu, Glenis K. Scadding, Paul D. Scanlon, Rebecca E. Schane, Marvin I. Schwarz, Fabian Sebastian, Jonathan E. Sevransky, Lori Shah, Penny Shaw, David W. Shimabukuro, Kathy E. Sietsema, Anita K. Simonds, Arthur S. Slutsky, Stephen G. Spiro, Daniel H. Sterman, Kaylan E. Stinson, Diane C. Strollo, Patrick J. Strollo, Darryl Y. Sue, Alvin S. Teirstein, Antoni Torres, Thierry Troosters, Elizabeth Tullis, Anil Vachani, Mauricio Valencia, J.M.M. van den Bosch, Johan Vansteenkiste, Theodoros Vassilakopoulos, Benoit Wallaert, Jadwiga A. Wedzicha, Athol Wells, Dorothy A. White, Jeanine P. Wiener-Kronish, Mark A. Woodhead, Prescott G. Woodruff, Stephen J. Wort, Jokke Wynants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0553e3d39bf66f52b03f3ec159ebe82a
https://doi.org/10.1016/b978-032304825-5.10079-0
https://doi.org/10.1016/b978-032304825-5.10079-0
Publikováno v:
Radiologic clinics of North America. 45(4)
Imaging techniques play a vital role in the diagnosis, staging, and follow-up of patients who have lung cancer. For this purpose, PET has become an important adjunct to conventional imaging techniques such as chest radiography, CT, ultrasonography, a